- Spot gold has just broken through the $4110.00/oz mark, now quoted at $4110.20/oz, up 1.08% on the day; COMEX gold futures main contract is now quoted at $4169.30/oz, up 1.76% on the day.
- US Stock Market Movement | Cloud Computing Service Provider NEBIUS (NBIS.US) Shares Surge Over 30%
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Cosmos Health CEO Grigorios Siokas acquires 766,284 common shares valued at $140,000
- Big Tree Cloud Holdings files Form 3 for director Yu Guo
- Lingotes Especiales insider-linked buyer Corporacion Oudalui spends EUR 64,217 on shares
- ATCO Q2 FY26 earnings attributable to shareholders rise 37.5% to $88 million; revenue climbs 13.9% to $1.32 billion
- Wavestone holds annual shareholder meeting; turnout 86.94%
- Roche sues Biocon over proposed breast-cancer drug copy
- Schneider National EVP Intermodal & Logistics Michael Baumgardt files initial beneficial ownership statement
- AMEX HALT ADD INFO LST 7.057800
- NYSE HALT WATSCO INC <WSOb.N> ADD INFO LST $317.630000
- Origin Bank hires Klein as Dallas relationship manager
- Lee Enterprises director Herbert W. Moloney III retires from board
- Leidos unit Gibbs & Cox Australia to design floating dry dock for nuclear-powered submarines
- Fair Isaac Down Over 15%, on Pace for Largest Percent Decrease Since May 2025 -- Data Talk
- Sebata delays FY2026 audited results release to Aug. 14
- Logitech appoints Henry Levak as Team Workspace Solutions general manager
- Chipotle Mexican Grill Up Over 11%, on Pace for Largest Percent Increase Since April 2023 -- Data Talk
- Lexaria Bioscience to execute 1-for-15 reverse stock split Aug. 3
- Dow Jones Top Company Headlines at 11 AM ET: Amazon's Zoox Gets Clearance to Start Paid Robotaxi Rides | NYSE ...
- US To Sell $52 Bln In 52-Week Bills Tue
- Dow Jones 11:00 AM Averages
- US To Sell $79 Bln In 6-Month Bills Mon
- US To Sell $95 Bln In Reopened 6-Week Bills Tue
- Holland America Line opens bookings for Zuiderdam post-renovation Europe cruises
- Banca Mediolanum says director Redaelli loses independent status effective July 25, 2026
- NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:58 AM
- Banca Mediolanum director Redaelli loses independence status from July 25, 2026
- Boreal Gold hits 15.54 g/t gold over 2.41 m in GR-26-149 at North Star project in Manitoba
- Correction to Amazon's Zoox Article -- WSJ
- EMCOR Up Over 18%, On Pace for Largest Percent Increase Since December 2008 -- Data Talk
- Eurobank 1H FY26 net profit rises 6.8% to €738 million; adjusted net profit climbs 9.2% to €776 million
- Vibra Energia posts transcript of Q1 2026 earnings call
- MarketAxess Up Over 29%, on Pace for Largest Percent Increase Since October 2008 -- Data Talk
- Alfil Patrimonial Socimi shareholders approve 2025 annual accounts
- Altech Batteries ends CERENERGY project in Germany
- PriceSmart director Sherry S. Bahrambeygui disposes of 2,100 shares worth $404,187.4
- Virtus Invst Partners 2Q Net $44.6M >VRTS
- Hilton Grand Vacations 2Q Net $12M >HGV
- Yum Brands 2Q EPS $3.08 >YUM
- Virtus Invst Partners 2Q Rev $201.4M >VRTS
- Altria Sees FY Adj EPS $5.61-Adj EPS $5.72 >MO
- Altria 2Q EPS $1.37 >MO
- Altria 2Q Adj EPS $1.48 >MO
- Altria 2Q Smokeable Products Segment Rev $5.39B >MO
- Myers Industries 2Q EPS 53c >MYE
- Yum Brands 2Q Worldwide Same-Store Sales Up 3% >YUM
- Yum Brands 2Q KFC Division Same-Store Sales Up 2% >YUM
- Yum Brands 2Q Pizza Hut Division Same-Store Sales Down 1% >YUM
- Yum Brands 2Q Taco Bell Division Same-Store Sales Up 7% >YUM
- Myers Industries 2Q Sales $179.2M >MYE
- Virtus Invst Partners 2Q EPS $6.68 >VRTS
- Republic Airways Holdings 2Q Net $31.2M >RJET
- Republic Airways Holdings 2Q EPS 68c >RJET
- Dow Jones Top Financial Services Headlines at 7 AM ET: BBVA Raises Profitability Outlook, Plans $2.3 Billion Buyback | Societe ...
- Yum Brands 2Q Worldwide Systems Sales Ex-Forex Up 5% >YUM
- Crocs 2Q Net $204.9M >CROX
- SunCoke Energy 2Q EPS 15c >SXC
- SunCoke Energy 2Q Net $13.1M >SXC
- Huntington Ingalls 2Q EPS $5.27 >HII
- Huntington Ingalls 2Q Net Contract Awards $6.7B >HII
- Huntington Ingalls 2Q Net $208M >HII
- Tradeweb Markets 2Q Net $181.3M >TW
- Madrigal Pharmaceuticals 2Q Loss/Shr $1.99 >MDGL
- AMC Global Media 2Q Loss $21.9M >AMCX
- AMC Global Media 2Q Rev $547.5M >AMCX
- TriNet Group 2Q EPS $1.15 >TNET
- TriNet Group 2Q Adj EPS $1.55 >TNET
- Builders FirstSource 2Q Loss/Shr 4c >BLDR
- Oil States 2Q EPS 10c >OIS
- Crocs 2Q Rev $1.18B >CROX
- Crocs 2Q Adj EPS $4.55 >CROX
- OneWater Marine 3Q Rev $530.7M >ONEW
- OneWater Marine 3Q EPS 69c >ONEW
- Hilton Grand Vacations 2Q Member Count 721,896 >HGV
- Builders FirstSource 2Q Sales $3.86B >BLDR
- Hilton Grand Vacations 2Q Adj EPS 89c >HGV
- Hilton Grand Vacations 2Q EPS 15c >HGV
- Neogen 4Q Loss $11.3M >NEOG
- Neogen 4Q Loss/Shr 5c >NEOG
- Bristol Myers Squibb 2Q Legacy Portfolio Rev Fell 4% to $5.42B >BMY
- Bristol Myers Squibb: In Legacy Portfolio, Demand Increased for Eliquis in 2Q, Which Was More Than Offset by Expected Continued Generic Impacts Across Remainder of Portfolio >BMY
- Bristol Myers Squibb 2Q Eliquis Revenue Rose 22% to $4.48B >BMY
- Bristol Myers Squibb 2Q U.S. Revenue Rose 6% to $8.99B >BMY
- Bristol Myers Squibb 2Q International Revenue Rose 6% to $3.98B >BMY
- Bristol Myers Squibb: Growth Portfolio Continues to Deliver, Represents Expanding Share of Overall Business >BMY
- Bristol Myers Squibb: As Result of Our Consistent Execution and Continued Momentum, Raising 2026 Full-Year Outlook >BMY
- Bristol Myers Squibb Raises 2026 View To Rev $49B-$50B Vs Prior Guidance $46B-$47.5B >BMY
- Bristol Myers Squibb: Operating Expenses in 2026 Now Expected to Be About $16.5B Due to Increased Investment Behind Key Pipeline Programs and New Product Launches >BMY
- Bristol Myers Squibb Had Seen 2026 Operating Expenses at About $16.3B >BMY
- Bristol Myers Squibb Now Sees Total Worldwide Eliquis Revenue Increasing 20%-25% in 2026 Vs Year-Ago >BMY
- Bristol Myers Squibb Had Seen Total Worldwide Eliquis Revenue Increasing 10%-15% in 2026 >BMY
- Bristol Myers Squibb: 2026 Guidance Excludes Impact of Any Potential Future Strategic Acquisitions, Divestitures and Impact of Future Acquired IPRD Charges and Licensing Income Incurred After June 30 >BMY
- American Electric Power Reaffirms Annual Operating Earnings Growth Rate of 7%-9% Through 2030 >AEP
- Phathom Pharmaceuticals 2Q Rev $74.3M >PHAT
- Bristol Myers Squibb: 2Q Growth Portfolio Revenue Increase Primarily Driven by Opdivo Qvantig, Reblozyl, Camzyos, Opdualag and Breyanzi >BMY
